The current first-line treatment for leishmaniasis, a skin disease that can cause disfiguring ulcers, is grueling and frequently fails. A new study pinpoints genetic factors that predict whether a patient will respond well to treatment. The work could inform the creation of prognostic tests that could help clinicians personalize therapies for individual patients.
from Skin Care News -- ScienceDaily https://ift.tt/34dU6kF
No comments:
Post a Comment